未登录

P

Paige Lewis

centers for disease control & prevention - usa

H指数:26

被引数:1,824

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adverse events following purified chick embryo cell rabies vaccine in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 2006-2016

TRAVEL MEDICINE AND INFECTIOUS DISEASE

IF4.7

2019-05-016

OAAI

Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017

2009-2017美国疫苗不良事件报告系统 (VAERS) 中二价人乳头瘤病毒疫苗的安全性

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2018-09-2121

OAAI

Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines

IF6.4

2018-07-0115

OAAI

Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2018-05-1826

OAAI

Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System

疫苗不良事件报告系统中人乳头瘤病毒疫苗接种后体位性心动过速综合征的报告

JOURNAL OF ADOLESCENT HEALTH

IF4.5

2017-11-0139

PREAI

Feasibility of Text Message Influenza Vaccine Safety Monitoring During Pregnancy

AMERICAN JOURNAL OF PREVENTIVE MEDICINE

IF4.5

2017-09-017

OAAI

Surveillance of Adverse Events After Seasonal Influenza Vaccination in Pregnant Women and Their Infants in the Vaccine Adverse Event Reporting System, July 2010-May 2016

IF3.8

2016-12-1735

OAAI

Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990. 2015

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2016-07-1322

OAAI

Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12

LANCET INFECTIOUS DISEASES

IF31

2015-10-0113

PREAI

Deaths Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013

CLINICAL INFECTIOUS DISEASES

IF7.3

2015-05-2830

OAAI

Adverse Events following Haemophilus influenzae Type b Vaccines in the Vaccine Adverse Event Reporting System, 1990-2013

JOURNAL OF PEDIATRICS

IF3.5

2015-04-0116

OAAI

Reports to the Vaccine Adverse Event Reporting System after hepatitis A and hepatitis AB vaccines in pregnant women

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

IF8.4

2014-06-0137

OAAI

Risk of Fever After Pediatric Trivalent Inactivated Influenza Vaccine and 13-Valent Pneumococcal Conjugate Vaccine

JAMA PEDIATRICS

IF18

2014-03-0148

OAAI

Safety of Influenza A (H1N1) 2009 Live Attenuated Monovalent Vaccine in Pregnant Women

OBSTETRICS AND GYNECOLOGY

IF4.7

2013-12-0126

PREAI

Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006-2012

2006向美国VAERS报告轮状病毒疫苗后肠套叠-2012

IF6.4

2013-06-0180

PREAI

Unintentional transfer of vaccinia virus associated with smallpox vaccines ACAM2000® compared with Dryvax®

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2013-04-0915

OAAI

Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans

AMERICAN JOURNAL OF EPIDEMIOLOGY

IF4.8

2012-05-1170

OAAI

Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010

CLINICAL INFECTIOUS DISEASES

IF7.3

2012-03-2215

PREAI

Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting System

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

IF8.4

2011-11-0197

OAAI

Invasive group a streptococcal infection in older adults in long-term care facilities and the community, united states, 1998-2003

EMERGING INFECTIOUS DISEASES

IF6.6

2007-12-0130

OAAI